348 results
Comparison between OFR and QFR
06 Oct 2020
The aim of this study was to evaluate the diagnostic performance of OCT-based optical flow ratio (OFR) in unselected patients and compare it with angiography-based quantitative flow ratio (QFR), using wire-based FFR as reference standard.
Authors :
Prognostic impact of residual anatomic disease burden after functionally complete revascularization
07 Oct 2020
This registry-based study evaluated the clinical outcomes of patients who underwent functionally complete revascularisation as assessed by post PCI FFR >0.80 at two years according to Residual Syntax Scores.
Reviewer
Sex differences in long‐term outcomes in patients with deferred revascularization following fractional flow reserve assessment
02 Oct 2020
International collaboration registry of comprehensive physiologic evaluation
Reviewer
Reviewer
Continuous intracoronary versus standard intravenous infusion of adenosine for fractional flow reserve assessment: the HYPEREMIC trial
30 Sep 2020
The aim of this study was to evaluate the accuracy of a continuous intracoronary (IC) adenosine infusion, administered through the novel HYPEREM™IC over-the-wire microcatheter, to measure fractional flow reserve (FFR).
Authors :
The DEFINE-FLOW study combined CFR and FFR assessment
19 Oct 2020
At TCT Connect 2020, Nils Johnson presented the results of the DEFINE-FLOW study. Carlos Collet provides a summary of the key messages.
Author
TARGET FFR: A randomized trial of physiology-guided PCI optimization
19 Oct 2020
At TCT Connect 2020, Damien Collison presented the results of the TARGET FFR trial. Carlos Collet provides a summary of the key messages.
Author
XIENCE 90/28: Assessment of three-month and one-month DAPT after everolimus-eluting stents in high-bleeding risk patients
23 Oct 2020
At TCT Connect 2020, Roxana Mehran and Marco Valgimigli presented the results of the XIENCE 90/28 trial. Watch this interview of Roxana Mehran by Francesco Costa.
Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020
19 Oct 2020
Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!
Author
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!
17 Oct 2020
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.
Author
PCRonline @ TCT Connect 2020
25 Sep 2020
View reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 online edition of TCT Connect. Check out the list here!
